These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 9425390)

  • 1. Increased thyrotrophin levels and loss of the nocturnal thyrotrophin surge in Sheehan's syndrome.
    Abucham J; Castro V; Maccagnan P; Vieira JG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):515-22. PubMed ID: 9425390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal circadian rhythm and increased non-pulsatile secretion of thyrotrophin in Sheehan's syndrome.
    MacCagnan P; Oliveira JH; Castro V; Abucham J
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):439-47. PubMed ID: 10583310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity.
    Oliveira JH; Persani L; Beck-Peccoz P; Abucham J
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1694-9. PubMed ID: 11297605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary function tests in Sheehan's syndome.
    Shahmanesh M; Ali Z; Pourmand M; Nourmand I
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):303-11. PubMed ID: 6771067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum thyrotropin concentrations in patients with Sheehan's syndrome: reevaluation of the usefulness in the diagnosis].
    Isotani H; Takamatsu J; Kitaoka H; Ikegami Y; Majima T; Sakane S; Majima M; Takeda K; Mozai T
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):22-30. PubMed ID: 3132405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children.
    Portes ES; Oliveira JH; MacCagnan P; Abucham J
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):183-9. PubMed ID: 10931099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serum.
    Scriba PC; Bauer M; Emmert D; Fateh-Moghadam A; Hofmann GG; Horn K; Pickardt CR
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):629-43. PubMed ID: 115194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man.
    Ekman AC; Vakkuri O; Ekman M; Leppäluoto J; Ruokonen A; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2627-32. PubMed ID: 8675588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal serum thyrotropin (TSH) surge and the TSH response to TSH-releasing hormone: dissociated behavior in untreated depressives.
    Bartalena L; Placidi GF; Martino E; Falcone M; Pellegrini L; Dell'Osso L; Pacchiarotti A; Pinchera A
    J Clin Endocrinol Metab; 1990 Sep; 71(3):650-5. PubMed ID: 2118539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relations between Sheehan's syndrome and empty sella turcica. A functional study apropos of 6 cases].
    López de la Torre Casares M; Gargallo Fernández M; Moreno Esteban B; Rodríguez Arnao MD; Jara Albarrán A; Rodríguez Poyo-Guerrero P
    Med Clin (Barc); 1990 Jun; 95(1):1-4. PubMed ID: 2172669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia in a patient with Sheehan's syndrome.
    Kelestimur F
    South Med J; 1992 Oct; 85(10):1008-10. PubMed ID: 1411718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
    Spencer CA; Greenstadt MA; Wheeler WS; Kletzky OA; Nicoloff JT
    J Clin Endocrinol Metab; 1980 Oct; 51(4):771-5. PubMed ID: 6774994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Gouwy S; Stockman W; Weekers F; Schetz M; Lauwers P; Bouillon R; Bowers CY
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):599-612. PubMed ID: 9425400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea.
    Berga SL; Mortola JF; Girton L; Suh B; Laughlin G; Pham P; Yen SS
    J Clin Endocrinol Metab; 1989 Feb; 68(2):301-8. PubMed ID: 2493024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goitre, and the 'sick euthyroid syndrome'.
    Benker G; Raida M; Olbricht T; Wagner R; Reinhardt W; Reinwein D
    Clin Endocrinol (Oxf); 1990 Dec; 33(6):777-86. PubMed ID: 2128925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.